Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Pancreatic Cancer

Clinical trial condition

Metastatic Pancreatic Cancer

Explore clinical trials studying Metastatic Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

131 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Pancreatic Cancer trial results

Not Yet Recruiting

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

NCT04901741

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC)

NCT06688240

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

NCT06662669

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

NCT06621095

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Renji hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

NCT02077881

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +15 more
Locations: Stanford University Palo Alto, California, United States

Augusta University Augusta, Georgia, United States

University of Kentucy Lexington, Kentucky, United States

Washington University in St. Louis St Louis, Missouri, United States

View Trial Details

Completed

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

NCT05586516

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations: UO Oncologia of Azienda Ospedaliera Universitaria Integrata di Verona Verona, Italy

Medical Oncology and Immunotherapy Unit, University Hospital of Siena Siena, Italy

Beatson West of Scotland Cancer Center Glasgow, United Kingdom

View Trial Details

Completed

ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer

NCT01489865

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

NCT04789980

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, South Korea

View Trial Details

Completed

Niraparib + Dostarlimab + RT in Pancreatic Cancer

NCT04409002

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

NCT03693677

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Clinique privée de l'Europe Amiens, France

CHU Hôtel Dieu Angers, France

Hôpital privé Antony, France

CH Auxerre, France

View all 36 locations

View Trial Details